ロード中...
Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs
Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis, and cell cycle arrest in cancer cells. Recently, their use has been clinically validated in cancer patients resultin...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
e-Century Publishing Corporation
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3056563/ https://ncbi.nlm.nih.gov/pubmed/21416059 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|